Merit Medical Systems
MMSI
About: Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Employees: 7,400
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
2,164% more call options, than puts
Call options by funds: $85.5M | Put options by funds: $3.78M
4% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 51
3% more repeat investments, than reductions
Existing positions increased: 137 | Existing positions reduced: 133
0% more funds holding in top 10
Funds holding in top 10: 3 [Q1] → 3 (+0) [Q2]
0.37% less ownership
Funds ownership: 106.29% [Q1] → 105.92% (-0.37%) [Q2]
1% less funds holding
Funds holding: 374 [Q1] → 372 (-2) [Q2]
11% less capital invested
Capital invested by funds: $6.61B [Q1] → $5.85B (-$758M) [Q2]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
|
Wells Fargo
Larry Biegelsen
|
$100
|
Overweight
Maintained
|
31 Jul 2025 |
|
Raymond James
Jayson Bedford
|
$102
|
Outperform
Maintained
|
31 Jul 2025 |
|
Piper Sandler
Jason Bednar
|
$105
|
Overweight
Maintained
|
31 Jul 2025 |
|
Barrington Research
Michael Petusky
|
$103
|
Outperform
Maintained
|
31 Jul 2025 |
|
Needham
Mike Matson
|
$108
|
Buy
Reiterated
|
18 Jul 2025 |
Financial journalist opinion
Based on 8 articles about MMSI published over the past 30 days
